MedTech Europe (MTE)

Tweet this page
How to read and use this data card.

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

800,000€ - 899,999€

Financial year: 01/01/2019 - 01/12/2019

Lobbyists declared: 2.5 FTE (10)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.


Lobbyists with EP accreditation: 0

Meetings with European Commission: 29

Lobbying costs over the years:


MedTech Europe (MTE)

Registration on EU Transparency Register

433743725252-26 (First registered: 26 Dec 2016)

Goals / Remit

MedTech Europe is the European trade association representing the medical technology manufacturers that produce diagnostics, medical devices and digital health solutions in Europe. MedTech Europe's mission is to make safe medical technology available to more people.
MedTech Europe aims to:
* promote the value and contribution of the medical technology industry,
* raise awareness about the role that innovative medical technologies play in providing solutions to Europe’s ever-growing healthcare needs
* anticipate and respond to new business trends;
* develop scientific expertise on questions of economic, medical and technical nature related to the medical technology industry;
* collect, develop and communicate reliable data on a wide variety of issues to its members;
* provide services, support and information that add value to our members
* encourage the contribution of the medical technology to EU industrial competitiveness and sustainable healthcare systems


* Internal market legislation and any other legislation which impacts upon medical technologies * Files under the responsibility of the DG SANTE, DG GROW, DG RTD, DG ENVI, DG CNECT, DG JUST, DG TRADE, DG TAXUD and DG NEAR with particular focus on health, medical devices and IVDs, Innovation * Implementation of Regulation (EU) 2017/746 on in vitro diagnostic medical devices and Regulation (EU) 2017/745 on medical devices * Blood, tissues and cells legislation * Animal by-products legislation * The General Data Protection Regulation (EU) 2016/679 * Implementation of the late payments directive * Policies, Initiatives related to Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HAIs) * EU Health Technology Assessment * Cross-Border Health Care * Health system performance assessments / EU semester * Environmental regulations and their implementation (e.g., The WEEE and RoHS Directives, and the REACH, POPs and Biocidal Products Regulations) * The European Green Deal * Corporate Social Responsibility * General Product Safety Directive * Patient safety and quality of care * EU Directive on Procurement * Public Procurement of Innovation Solutions * Research Framework Program * Public Private Partnership in Healthcare * E-privacy, Digital Single Market initiatives * Digital transformation of health and care * Regulation (EU) 2019/881 on ENISA and on information and communications technology cybersecurity certification” * The European Health Data Space * Artificial intelligence * Collective Redress *Product Liability * Withdrawal of the United Kingdom from the European Union * Bilateral and multilateral trade agreements * Customs procedures and tariffs * Resolution of technical barriers to trade


Head office:
40 rue Joseph II
Brussels 1000

Tel: 32 7722212